In Vivo: strategic insights for life sciences decision-maker...
Centessa ‘Creates Pharma Pipeline Overnight’ Using Novel R&D Approach
03 Mar 2021
With $250m in series A funding, Cambridge, MA-based Centessa is looking to upend traditional biopharma R&D models. The new company...